Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma.
Dig Liver Dis
; 39(7): 634-41, 2007 Jul.
Article
em En
| MEDLINE
| ID: mdl-17531561
ABSTRACT
BACKGROUND:
Despite treatment, enteropathy-associated T-cell lymphoma has a very poor outcome. Chemotherapy can be complicated by small bowel perforation, gastrointestinal bleeding and development of enterocolic fistulae. Here we report on the feasibility, safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma (three upfront and one at relapse), with or without prior partial small bowel resection.METHODS:
Four patients [two males, two females, mean age 65 years (range 60-69 years)] received high-dose chemotherapy followed by autologous stem cell transplantation. Partial small bowel resection has been performed in three patients.RESULTS:
All four patients completed the mobilization and leucopheresis procedures successfully and subsequently received conditioning chemotherapy and transplantation. Engraftment occurred in all patients. No major non-haematological toxicity or transplantation-related mortality was observed. One patient has ongoing complete remission 32 months after transplantation. Three patients died from relapse within few months after autologous stem cell transplantation.CONCLUSIONS:
Autologous stem cell transplantation seems unsatisfactory for patients with enteropathy-associated T-cell lymphoma. More intensive conditioning and aggressive chemotherapy with/or without targeted immunotherapy as well as allogenous stem cell transplantation needs to be explored.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doença Celíaca
/
Linfoma de Células T
/
Condicionamento Pré-Transplante
/
Transplante de Células-Tronco de Sangue Periférico
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article